Brief: Mirum Pharmaceuticals Enters Into Definitive Agreement To Acquire Bluejay Therapeutics
08/12/2025 13:00
Dec 8 (Reuters) - Mirum Pharmaceuticals Inc MIRM.O: MIRUM PHARMACEUTICALS: DEAL APPROVED BY BOARDS OF BOTH COS AND EXPECTED TO CLOSE IN Q1 2026 MIRUM PHARMACEUTICALS ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE BLUEJAY THERAPEUTICS MIRUM PHARMACEUTICALS: ENTERED INTO DEFINITIVE AGREEMENT WITH SYNDICATE OF HEALTHCARE INVESTORS FOR A PRIVATE PLACEMENT MIRUM PHARMACEUTICALS: TO BUY BLUEJAY FOR $250 MILLION IN CASH, $370 MILLION IN CO'S COMMON STOCK & SALES-BASED MILESTONE PAYMENTS OF UPTO $200 MILLION IN CASH MIRUM PHARMACEUTICALS: AZURE PHASE 3 PROGRAM CURRENTLY ENROLLING PATIENTS, WITH TOP-LINE DATA EXPECTED IN 2H 2026 WITH BLA SUBMISSION, LAUNCH IN 2027 MIRUM PHARMACEUTICALS: PRIVATE PLACEMENT EXPECTED TO CLOSE CONCURRENTLY WITH ACQUISITION & RESULT IN GROSS PROCEEDS TO CO OF ABOUT $200 MILLION MIRUM PHARMACEUTICALS: BRELOVITUG BEING EVALUATED IN AZURE PHASE 3 REGISTRATIONAL PROGRAM FOR HDV Further company coverage: MIRM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mirum Pharmaceuticals
See all newsMirum Pharmaceuticals Q3 net product sales surge, outlook raised
Brief: Mirum Pharmaceuticals Announces Positive Results From Cohort 2 Of The Pivotal Progress Study Of Atebrioz™ (Zilurgisertib) In Pediatric Patients Aged 6 To <12 Years With Fibrodysplasia Ossificans Progressiva
Mirum climbs on positive late-stage trial results for liver disease drug
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX